Baillie Gifford & CO Zoetis Inc. Transaction History
Baillie Gifford & CO
- $114 Billion
- Q4 2025
A detailed history of Baillie Gifford & CO transactions in Zoetis Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 150,845 shares of ZTS stock, worth $17.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
150,845Holding current value
$17.9 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
2,043Shares Held
425MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...